Figure 4From: Is mTOR inhibition a systemic treatment for tuberous sclerosis?Facial angiofibroma before and during Everolimus treatment. Facial angiofibroma of the same boy presented in Figure 1 at baseline (A) and after 84 weeks of treatment with Everolimus (B).Back to article page